» Articles » PMID: 30074262

Stem Cell- and Gene-based Therapies As Potential Candidates in Alzheimer's Therapy

Overview
Journal J Cell Biochem
Date 2018 Aug 4
PMID 30074262
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, which is associated with impairments of memory, thinking, language, and reasoning. Despite extensive research aiming at the treatment of AD, durable and complete remissions are rare. Hence, new therapeutic approaches are required. Among various therapeutic approaches, stem cells (ie, neural stem cells, mesenchymal stem cells, and embryonic stem cells) and delivery of protective genes such as encoding nerve growth factor, APOE, and glial cell-derived neurotrophic factor have generated promise in AD therapy. Here, we summarized a variety of effective therapeutic approaches (ie, stem cells, and genes) in AD therapy.

Citing Articles

Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.

Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A Front Med (Lausanne). 2024; 11:1474043.

PMID: 39736972 PMC: 11682909. DOI: 10.3389/fmed.2024.1474043.


Proposed Mechanisms of Cell Therapy for Alzheimer's Disease.

Belousova E, Salikhova D, Maksimov Y, Nebogatikov V, Sudina A, Goldshtein D Int J Mol Sci. 2024; 25(22).

PMID: 39596443 PMC: 11595163. DOI: 10.3390/ijms252212378.


Insights on the Characteristics and Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes for Mitigation of Alzheimer's Disease's Pathogenicity: A Systematic Review.

Mohammed Yousuf Abdi S, Al-Bakri S, Nordin N Cell Biochem Biophys. 2024; .

PMID: 39436580 DOI: 10.1007/s12013-024-01598-x.


A Severe Alzheimer's Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant.

Honda Pazili T Case Rep Neurol Med. 2024; 2024:8353492.

PMID: 39040486 PMC: 11262880. DOI: 10.1155/2024/8353492.


Adipose Tissue-Derived Mesenchymal Stem Cells Alter Metabolites of Brain Cholesterol Homeostasis in An Alzheimer's Model.

Karimi Darabi M, Nazeri Z, Rafeeinia A, Pezeshki S, Kheirollah A, Farbood Y Cell J. 2023; 25(11):764-771.

PMID: 38071408 PMC: 10711292. DOI: 10.22074/cellj.2023.1999622.1272.